HemoShear, Takeda in liver disease deal

By Alicia Parker | Oct 20, 2017 | 7:21 PM GMT

HemoShear Therapeutics LLC (Charlottesville, Va.) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) partnered to discover and develop therapeutics for liver diseases including non-alcoholic steatohepatitis (NASH). HemoShear will receive